Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
3
×
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
biotech
eli lilly
fda
new york blog main
new york top stories
4d molecular therapeutics
acne
acorda therapeutics
agenus
alkermes
allergan
ampyra
apokyn
apomorphine
astrazeneca
auris health
avexis
bayer
biomx
bladder cancer
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
broad institute of mit and harvard
buprenorphine
cancer
cancer immunotherapy
cancer vaccines
car-t immunotherapy
cariprazine
celgene
centers for medicare and medicaid services
dalfampridine
What
drug
3
×
fda
3
×
treatment
approved
disease
acorda
alkermes
antipsychotic
benefits
bio
caveats
commonly
companies
cope
designed
digital
effect
epidemic
episodes
fatty
favor
frenzied
friday
gain
gets
growing
help
known
late
led
liver
looms
meant
medications
medicine
merck
nash
new
news
nod
Language
unset
Current search:
abbvie
×
fda
×
drug
×
@xconomy.com
3 years ago
FDA Panel Vote Weighs in Favor of Alkermes Psyche Drug, With Caveats
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
